POLR2A and malignant mesothelioma: Therefore, we examined the pattern of expression of POLR2A in tumor sections from patients with malignant mesothelioma (Fig. 7A), and in JMN (Fig. 6D) and MSTO/CD26 (Fig. 7B) cells, by immunohistochemical analysis.